Published in J Renal Inj Prev on April 21, 2016
Tempol effect on epithelial-mesenchymal transition induced by hyperglycemia. J Nephropathol (2016) 0.75
Evaluation of selenium on kidney function following ischemic injury in rats; protective effects and antioxidant activity. J Renal Inj Prev (2016) 0.75
The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Anal Biochem (1996) 28.76
Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev (2002) 6.05
Studies of the diabetogenic action of streptozotocin. Proc Soc Exp Biol Med (1967) 2.55
Pathogenetic mechanisms of diabetic nephropathy. J Am Soc Nephrol (2005) 2.18
Measurement of lipid peroxidation. Free Radic Res (1998) 1.91
Oxidative stress in early diabetic nephropathy: fueling the fire. Nat Rev Endocrinol (2010) 1.51
New insights into the pathophysiology of diabetic nephropathy: from haemodynamics to molecular pathology. Eur J Clin Invest (2004) 1.46
Reduction of renal superoxide dismutase in progressive diabetic nephropathy. J Am Soc Nephrol (2009) 1.23
Acceleration of diabetic renal injury in the superoxide dismutase knockout mouse: effects of tempol. Metabolism (2007) 1.10
Oxidative stress and gene expression of antioxidant enzymes in the renal cortex of streptozotocin-induced diabetic rats. Mol Cell Biochem (2003) 1.04
Antioxidant SOD mimetic prevents NADPH oxidase-induced oxidative stress and renal damage in the early stage of experimental diabetes and hypertension. Am J Nephrol (2008) 1.02
Tumor necrosis factor-alpha down-regulates human Cu/Zn superoxide dismutase 1 promoter via JNK/AP-1 signaling pathway. Free Radic Biol Med (2006) 1.00
Diet-induced renal changes in Zucker rats are ameliorated by the superoxide dismutase mimetic TEMPOL. Obesity (Silver Spring) (2009) 1.00
Reactive oxygen species, PKC-beta1, and PKC-zeta mediate high-glucose-induced vascular endothelial growth factor expression in mesangial cells. Am J Physiol Endocrinol Metab (2007) 0.95
Serum selenium and glutathione peroxidase concentrations in type 2 diabetes mellitus patients. Prim Care Diabetes (2008) 0.93
Renal and metabolic effects of tempol in obese ZSF1 rats--distinct role for superoxide and hydrogen peroxide in diabetic renal injury. Metabolism (2008) 0.93
Hyperglycemia induced oxidative stress in type-1 and type-2 diabetic patients with and without nephropathy. Cell Mol Biol (Noisy-le-grand) (2007) 0.92
Effect of exercise on kidney function, oxidative stress, and inflammation in type 2 diabetic KK-A(y) mice. Exp Diabetes Res (2012) 0.91
Interleukin-1alpha downregulates extracellular-superoxide dismutase in human corneal keratoconus stromal cells. Mol Vis (2007) 0.89
Race-specific differences in antioxidant enzyme activity in patients with type 2 diabetes: a potential association with the risk of developing nephropathy. Diabetes Care (2005) 0.87
Tempol reduces podocyte apoptosis via PARP signaling pathway in experimental diabetes mellitus. Nephron Exp Nephrol (2012) 0.86
The protective effects of beta-casomorphin-7 against glucose -induced renal oxidative stress in vivo and vitro. PLoS One (2013) 0.86
Beneficial effect of myricetin on renal functions in streptozotocin-induced diabetes. Clin Exp Med (2011) 0.86
Long-term treatment with nebivolol attenuates renal damage in Zucker diabetic fatty rats. J Hypertens (2011) 0.86
Relationship between Oxidant/Antioxidant Markers and Severity of Microalbuminuria in the Early Stage of Nephropathy in Type 2 Diabetic Patients. J Diabetes Res (2013) 0.84
Relationship between total oxidant status and severity of diabetic nephropathy in type 2 diabetic patients. Nutr Metab Cardiovasc Dis (2007) 0.83
Transcriptional regulation and environmental induction of gene encoding copper- and zinc-containing superoxide dismutase. Methods Enzymol (2002) 0.82
Aliskiren reduces albuminuria and oxidative stress, and elevates glomerular filtration rates in Japanese patients with advanced diabetic nephropathy. Hypertens Res (2010) 0.81
Exogenous SOD mimetic tempol ameliorates the early retinal changes reestablishing the redox status in diabetic hypertensive rats. Invest Ophthalmol Vis Sci (2010) 0.81
NF-E2-related factor 2 and its role in diabetic nephropathy. Iran J Kidney Dis (2013) 0.79
Urinary excretion of neutrophil gelatinase-associated lipocalin in diabetic rats. Oxid Med Cell Longev (2014) 0.79
Association between plasma selenium and glutathione peroxidase levels and severity of diabetic nephropathy in patients with type two diabetes mellitus. Nephrourol Mon (2014) 0.77
Propofol Attenuates Toxic Oxidative Stress by CCl4 in Liver Mitochondria and Blood in Rat. Iran J Pharm Res (2014) 0.80
Comparison of urinary oxidative biomarkers in Iranian children with autism. Res Dev Disabil (2014) 0.76
A glimpse of diabetic nephropathy. J Nephropharmacol (2016) 0.75
Ameliorative effect of Matricaria chamomilla .L on paraquat: Induced oxidative damage in lung rats. Pharmacognosy Res (2014) 0.75
Tempol effect on epithelial-mesenchymal transition induced by hyperglycemia. J Nephropathol (2016) 0.75
The Effect of Green Tea Extract on Oxidative Stress and Spatial Learning in Streptozotocin-diabetic Rats. Iran J Pharm Res (2017) 0.75
Oxidative toxic stress in workers occupationally exposed to ceramic dust: A study in a ceramic manufacturing industry. Work (2016) 0.75
Oxidative stress biomarkers in endometrial secretions: A comparison between successful and unsuccessful in vitro fertilization cycles. J Reprod Immunol (2016) 0.75
Antioxidative effects of propofol vs. ketamin in individuals undergoing surgery. Arch Iran Med (2014) 0.75